[Enterohemorrhagic Escherichia coli infection]

Nihon Rinsho. 2004 May:62 Suppl 5:472-7.
[Article in Japanese]
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Combined Modality Therapy
  • Escherichia coli Infections / diagnosis
  • Escherichia coli Infections / microbiology
  • Escherichia coli Infections / therapy*
  • Escherichia coli O157* / pathogenicity
  • Female
  • Hemolytic-Uremic Syndrome / etiology
  • Hemolytic-Uremic Syndrome / prevention & control
  • Hemolytic-Uremic Syndrome / therapy
  • Humans
  • Plasma Exchange
  • Platelet Aggregation Inhibitors / therapeutic use
  • Prognosis
  • Renal Dialysis
  • Shiga Toxin 1 / biosynthesis
  • Shiga Toxin 1 / toxicity
  • Shiga Toxin 2
  • Shiga Toxins / biosynthesis
  • Shiga Toxins / toxicity

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Platelet Aggregation Inhibitors
  • Shiga Toxin 1
  • Shiga Toxin 2
  • Shiga Toxins
  • verocytotoxin 2